A convexity meningioma is a dural-based tumor arising from the cerebral convexity dura mater, away from the major dural venous sinuses and falx. These tumors originate from the outer convex surface of the brain and grow inward toward the cortical surface, displacing but initially respecting the arachnoid plane. Their surgical behavior is primarily determined by their relationship to the underlying cortex and cortical veins rather than venous sinuses.

 

Q. What is the cell of origin and embryologic basis of convexity meningiomas?

 

Convexity meningiomas arise from arachnoid cap cells located within the arachnoid villi and granulations distributed along the convexity dura. These cells derive from neural crest–mesenchymal elements and retain proliferative potential throughout life. There is no distinct embryologic difference between convexity and other intracranial meningiomas, but the widespread distribution of arachnoid cap cells along the convexity explains the high frequency of tumors at this site.

 

Q. What histopathologic subtypes and molecular features are relevant to convexity meningiomas?

 

Common histologic subtypes include meningothelial, fibrous, and transitional meningiomas, which are typically WHO grade 1. Convexity meningiomas frequently harbor NF2 mutations and chromosome 22q deletions. Higher-grade tumors demonstrate increased mitotic activity, brain invasion, necrosis, or sheeting architecture and show more complex molecular alterations that correlate with aggressive behavior and recurrence.

 

Q. What is the epidemiology and incidence of convexity meningiomas?

 

Convexity meningiomas are among the most common intracranial meningiomas, accounting for approximately 30 percent of cases. They typically occur in middle-aged and elderly patients and show a female predominance. Their frequency reflects the large surface area of the cerebral convexity and the widespread distribution of arachnoid cap cells.

 

Q. What is the natural history and growth behavior of convexity meningiomas?

 

Convexity meningiomas generally grow slowly and remain asymptomatic for long periods. Progressive enlargement leads to mass effect on the adjacent cortex, resulting in seizures, focal neurological deficits, or raised intracranial pressure. Unlike parasagittal tumors, venous sinus compromise is uncommon, but cortical vein involvement may contribute to edema and neurological symptoms. Untreated tumors may eventually cause significant morbidity due to cortical compression and edema.

 

Q. How are convexity meningiomas anatomically distributed, and how does location influence clinical presentation?

 

Convexity meningiomas arise over the frontal, parietal, temporal, or occipital lobes:

Frontal Convexity: Most common; often grow very large before detection, presenting with executive dysfunction, personality changes, or generalized seizures.

Parietal Convexity: Frequently present early with contralateral sensory deficits, apraxia, or focal motor seizures.

Temporal Convexity: Produce seizures, memory impairment, or sensory aphasia if the dominant hemisphere is involved.

Occipital Convexity: Typically present with contralateral homonymous visual field deficits. Overall, seizures are the most common presenting symptom across all sites, while headaches and signs of raised intracranial pressure occur with larger tumors causing mass effect.

 

Q. What key surgical anatomy, arachnoid planes, and cortical vein relationships dictate operative complexity and intraoperative risks?

 

The key surgical anatomy comprises the convexity dura, the underlying cortex, the intervening arachnoid plane, and superficial cortical veins.

 

Arachnoid Plane: Initially, the tumor displaces the cortex while respecting the arachnoid plane. Attenuation or loss of this plane, especially in higher-grade tumors, leads to cortical adherence or frank brain invasion. Preserving this plane during dissection avoids cortical contusion and seizures.

 

Cortical Veins: Cortical veins are frequently stretched, displaced, or encased along the tumor margin. Sacrifice or traction injury to these veins can lead to severe venous infarction, edema, and hemorrhage. Intraoperative risks are directly tied to these structures and are minimized by gentle handling, maintaining natural dissection planes, avoiding brain retraction, and performing early internal debulking.

 

Q. What are the characteristic CT features of convexity meningiomas?

 

On CT imaging, convexity meningiomas typically appear as well-circumscribed, hyperdense extra-axial masses along the cerebral convexity. Calcification may be present, particularly in long-standing tumors. Hyperostosis or focal thickening of the adjacent calvarium is common and reflects chronic dural involvement. CT also demonstrates mass effect, midline shift, and associated vasogenic edema, which may be disproportionate to tumor size in some cases.

 

Q. What are the MRI characteristics of convexity meningiomas?

 

On MRI, convexity meningiomas are usually isointense to slightly hypointense on T1-weighted images and iso- to hyperintense on T2-weighted images. They show intense, homogeneous enhancement following contrast administration and often demonstrate a dural tail. MRI accurately delineates the tumor–brain interface, cortical involvement, venous relationships, and the extent of peritumoral edema, all of which are critical for surgical planning.

 

Q. What imaging features suggest brain invasion or aggressive behavior in convexity meningiomas?

 

Imaging features suggestive of brain invasion or higher-grade behavior include irregular or lobulated tumor margins, loss of the cerebrospinal fluid cleft, heterogeneous enhancement, extensive peritumoral edema, and cortical signal changes adjacent to the tumor. These findings correlate with histologic brain invasion and are associated with increased recurrence risk.

 

Q. What are the important differential diagnoses of convexity lesions?

 

Differential diagnoses include dural metastasis, solitary fibrous tumor or hemangiopericytoma, lymphoma, glioma with dural contact, and granulomatous lesions. Features favoring meningioma include broad-based dural attachment, hyperostosis, homogeneous enhancement, and a dural tail.

 

Q. What are the overall management principles, decision criteria for extent of resection, and application of Simpson grading in convexity meningiomas?

 

The goal of management is complete surgical resection while preserving neurological function. Because convexity meningiomas are superficial and accessible, Simpson Grade I or II resection (complete tumor excision, coagulation/excision of involved dura, and resection of hyperostotic bone) is often achievable and provides low long-term recurrence rates.

The decision between gross total resection and subtotal resection is guided by:

 

Cortical & Venous Adherence: If the tumor is densely adherent to eloquent cortex or critical cortical veins without a clear arachnoid plane, subtotal resection is preferred to prevent severe neurological deficits or venous infarction.

 

Tumor Location & Functional State: Non-eloquent locations permit aggressive Simpson Grade I resection, whereas eloquent cortex demands a conservative approach along adherent interfaces.

 

Q. How will you surgically manage a convexity meningioma?

 

I will position the patient according to tumor location to allow gravity-assisted brain relaxation. Guided by neuronavigation, I will perform a tailored convexity craniotomy centered over the lesion that provides adequate exposure while minimizing brain retraction. I will open the dura in a curvilinear fashion hinged on the dural base. I will devascularize the tumor at its dural origin, perform thorough internal debulking to collapse the capsule, and carefully dissect the tumor wall away from the underlying cortex along the arachnoid plane. I will meticulously identify and preserve all cortical veins. Involved dura and hyperostotic bone will be excised when safe to achieve a low Simpson grade before completing a primary or graft dural closure.

 

Q. What immediate and delayed complications, including long-term morbidity, can occur after convexity meningioma surgery?

 

Immediate Complications: Postoperative seizures, transient or permanent focal neurological deficits, acute intraventricular or parenchymal hemorrhage, cerebral edema, and wound complications.

 

Delayed Complications & Long-Term Morbidity: Persistent epilepsy, delayed venous infarction from intraoperative venous compromise, chronic headaches, and subtle personality or executive function deficits (particularly following frontal resections). Higher-grade tumors or subtotal resections also carry a risk of late recurrence.

 

Q. What is the role of radiotherapy, and how are residual or recurrent convexity meningiomas managed?

 

Management of residual or recurrent tumors depends on growth rate, symptoms, patient status, and WHO grade:

 

Observation: Small, asymptomatic WHO grade 1 remnants may be followed with serial imaging.

 

Reoperation: Feasible and preferred for enlarging or symptomatic recurrent tumors in accessible locations, though surgical risk is higher due to scarring and venous adherence.

 

Radiation Therapy / SRS: Stereotactic radiosurgery (SRS) is indicated for small residual/recurrent lesions away from critical cortex or in patients unfit for reoperation. Fractionated radiotherapy is used for larger tumor volumes, WHO grade 2 (atypical), or WHO grade 3 (anaplastic) meningiomas to improve local tumor control.

 

Q. What factors influence prognosis in convexity meningiomas?

 

Prognosis is influenced primarily by WHO grade, extent of resection, presence of brain invasion, and molecular features. Simpson grade I or II resection is associated with excellent long-term control in WHO grade 1 tumors. Higher-grade tumors have increased recurrence risk and require closer surveillance and adjuvant therapy.

 

Q. What are the expected long-term outcomes and quality-of-life considerations in convexity meningioma patients?

 

Most patients with WHO grade 1 convexity meningiomas achieve good long-term survival and functional independence. Quality of life is determined by seizure control, preservation of neurological function, and avoidance of recurrence. Patients with higher-grade tumors may experience chronic morbidity related to repeated treatments.

 

Q. What follow-up and surveillance protocol do you recommend after treatment of convexity meningioma?

 

I recommend early postoperative MRI to establish a baseline, followed by surveillance imaging at six months and annually thereafter for WHO grade 1 tumors. More frequent imaging is advised for higher-grade tumors or subtotal resections. Long-term clinical follow-up focuses on neurological status, seizure control, and early detection of recurrence.